ZYUS Life Sciences Successfully Completes Brokered Subscription Receipt Financing and Reverse Takeover
Counsel to Stifel GMP
SGS acquires a majority stake in Nutrasource Pharmaceutical and Nutraceutical Services Inc. and its subsidiaries (“Nutrasource”)
Counsel to SGS
Numinus completes acquisition of Novamind
Counsel to Numinus Wellness Inc.
Sandoz Canada sells sterile injectable medicine manufacturing plant to Delpharm
Canadian counsel to Sandoz Canada Inc.
Levitee Labs enters into credit facility for up to $12 million
Counsel to RiverFort Global Opportunities PCC Ltd.
Mydecine closes spin-out of U.S. cannabis assets
Counsel to Mydecine Innovations Group
MYND Life Sciences closes fully subscribed $3 million non-brokered private placement
Counsel to MYND Life Sciences Inc.
Numinus, a pioneer in the psychedelic-assisted integrative health industry, closes $40 million bought deal financing
Counsel to Numinus Wellness Inc.
Mydecine Innovations Group closes $17.25 million bought deal public offering
Counsel to Mydecine Innovations Group
Delta Genomics completes asset sale of genotyping services to Neogen Canada Inc.
Counsel to Delta Genomics Centre
